Cargando…

Molecular basis of antibody binding to mucin glycopeptides in lung cancer

Glycopeptides bearing Tn epitopes are emerging targets for cancer diagnosis and immunotherapy. In this study, we analyzed membrane proteins containing O-glycosylated tandem repeat (TR) sequences in lung cancer patients of different types and stages, using gene microarray data in public domain. The e...

Descripción completa

Detalles Bibliográficos
Autores principales: QU, JIN, YU, HONGTAO, LI, FENGE, ZHANG, CHUNLEI, TRAD, AHMAD, BROOKS, CORY, ZHANG, BIN, GONG, TING, GUO, ZHI, LI, YUNSEN, RAGUPATHI, GOVIND, LOU, YANYAN, HWU, PATRICK, HUANG, WEI, ZHOU, DAPENG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725460/
https://www.ncbi.nlm.nih.gov/pubmed/26692014
http://dx.doi.org/10.3892/ijo.2015.3302
_version_ 1782411644787228672
author QU, JIN
YU, HONGTAO
LI, FENGE
ZHANG, CHUNLEI
TRAD, AHMAD
BROOKS, CORY
ZHANG, BIN
GONG, TING
GUO, ZHI
LI, YUNSEN
RAGUPATHI, GOVIND
LOU, YANYAN
HWU, PATRICK
HUANG, WEI
ZHOU, DAPENG
author_facet QU, JIN
YU, HONGTAO
LI, FENGE
ZHANG, CHUNLEI
TRAD, AHMAD
BROOKS, CORY
ZHANG, BIN
GONG, TING
GUO, ZHI
LI, YUNSEN
RAGUPATHI, GOVIND
LOU, YANYAN
HWU, PATRICK
HUANG, WEI
ZHOU, DAPENG
author_sort QU, JIN
collection PubMed
description Glycopeptides bearing Tn epitopes are emerging targets for cancer diagnosis and immunotherapy. In this study, we analyzed membrane proteins containing O-glycosylated tandem repeat (TR) sequences in lung cancer patients of different types and stages, using gene microarray data in public domain. The expression of Tn and glycopeptide epitopes on the surface of lung cancer cell lines were studied by monoclonal IgG antibodies 14A, 16A, and B72.3. The binding of mAbs to synthetic glycopeptides were studied by surface plasmon resonance. Nine mucin mRNAs were found to be expressed in lung cancer patients but at similar level to healthy individuals. At protein level, a glycopeptide epitope on cancer cell surface is preferably recognized by mAb 16A, as compared to peptide-alone (14A) or sugar-alone epitopes (B72.3). 14A and 16A favor clustered TR containing more than three TR sequences, with 10-fold lower Kd than two consecutive TR. B72.3 preferrably recognized clustered sialyl-Tn displayed on MUC1 but not other O-glycoproteins, with 100-fold stronger binding when MUC1 is transfected as a sugar carrier, while the total sugar epitopes remain unchanged. These findings indicate that clusters of both TR backbones and sugars are essential for mAb binding to mucin glycopeptides. Three rules of antibody binding to mucin glycopeptides at molecular level are presented here: first, the peptide backbone of a glycopeptide is preferentially recognized by B cells through mutations in complementarity determining regions (CDRs) of B cell receptor, and the sugar-binding specificity is acquired through mutations in frame work of heavy chain; secondly, consecutive tandem repeats (TR) of peptides and glycopeptides are preferentially recognized by B cells, which favor clustered TR containing more than three TR sequences; thirdly, certain sugar-specific B cells recognize and accommodate clustered Tn and sialyl-Tn displayed on the surface of a mucin but not other membrane proteins.
format Online
Article
Text
id pubmed-4725460
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-47254602016-01-31 Molecular basis of antibody binding to mucin glycopeptides in lung cancer QU, JIN YU, HONGTAO LI, FENGE ZHANG, CHUNLEI TRAD, AHMAD BROOKS, CORY ZHANG, BIN GONG, TING GUO, ZHI LI, YUNSEN RAGUPATHI, GOVIND LOU, YANYAN HWU, PATRICK HUANG, WEI ZHOU, DAPENG Int J Oncol Articles Glycopeptides bearing Tn epitopes are emerging targets for cancer diagnosis and immunotherapy. In this study, we analyzed membrane proteins containing O-glycosylated tandem repeat (TR) sequences in lung cancer patients of different types and stages, using gene microarray data in public domain. The expression of Tn and glycopeptide epitopes on the surface of lung cancer cell lines were studied by monoclonal IgG antibodies 14A, 16A, and B72.3. The binding of mAbs to synthetic glycopeptides were studied by surface plasmon resonance. Nine mucin mRNAs were found to be expressed in lung cancer patients but at similar level to healthy individuals. At protein level, a glycopeptide epitope on cancer cell surface is preferably recognized by mAb 16A, as compared to peptide-alone (14A) or sugar-alone epitopes (B72.3). 14A and 16A favor clustered TR containing more than three TR sequences, with 10-fold lower Kd than two consecutive TR. B72.3 preferrably recognized clustered sialyl-Tn displayed on MUC1 but not other O-glycoproteins, with 100-fold stronger binding when MUC1 is transfected as a sugar carrier, while the total sugar epitopes remain unchanged. These findings indicate that clusters of both TR backbones and sugars are essential for mAb binding to mucin glycopeptides. Three rules of antibody binding to mucin glycopeptides at molecular level are presented here: first, the peptide backbone of a glycopeptide is preferentially recognized by B cells through mutations in complementarity determining regions (CDRs) of B cell receptor, and the sugar-binding specificity is acquired through mutations in frame work of heavy chain; secondly, consecutive tandem repeats (TR) of peptides and glycopeptides are preferentially recognized by B cells, which favor clustered TR containing more than three TR sequences; thirdly, certain sugar-specific B cells recognize and accommodate clustered Tn and sialyl-Tn displayed on the surface of a mucin but not other membrane proteins. D.A. Spandidos 2015-12-18 /pmc/articles/PMC4725460/ /pubmed/26692014 http://dx.doi.org/10.3892/ijo.2015.3302 Text en Copyright © 2016, Spandidos Publications
spellingShingle Articles
QU, JIN
YU, HONGTAO
LI, FENGE
ZHANG, CHUNLEI
TRAD, AHMAD
BROOKS, CORY
ZHANG, BIN
GONG, TING
GUO, ZHI
LI, YUNSEN
RAGUPATHI, GOVIND
LOU, YANYAN
HWU, PATRICK
HUANG, WEI
ZHOU, DAPENG
Molecular basis of antibody binding to mucin glycopeptides in lung cancer
title Molecular basis of antibody binding to mucin glycopeptides in lung cancer
title_full Molecular basis of antibody binding to mucin glycopeptides in lung cancer
title_fullStr Molecular basis of antibody binding to mucin glycopeptides in lung cancer
title_full_unstemmed Molecular basis of antibody binding to mucin glycopeptides in lung cancer
title_short Molecular basis of antibody binding to mucin glycopeptides in lung cancer
title_sort molecular basis of antibody binding to mucin glycopeptides in lung cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725460/
https://www.ncbi.nlm.nih.gov/pubmed/26692014
http://dx.doi.org/10.3892/ijo.2015.3302
work_keys_str_mv AT qujin molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT yuhongtao molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT lifenge molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT zhangchunlei molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT tradahmad molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT brookscory molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT zhangbin molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT gongting molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT guozhi molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT liyunsen molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT ragupathigovind molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT louyanyan molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT hwupatrick molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT huangwei molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer
AT zhoudapeng molecularbasisofantibodybindingtomucinglycopeptidesinlungcancer